Abnormalities in genes can cause various diseases. Genomic abnormalities, including those acquired after birth, may be associated not only with tumor-related diseases such as cancer but also with the development of various other disorders. For patients with genomic abnormalities, early diagnosis and follow-up monitoring can help prevent or reduce disease occurrence and complications.

Our research team extracts genetic material from donated blood to study diseases prevalent among veterans and the genetic abnormalities associated with them. Based on these findings, we are developing new diagnostic methods. In addition, based on previous epidemiological studies on defoliant-related health effects, we are conducting genomics and metabolomics research using advanced medical technologies, with the goal of improving diagnostic methods, discovering new treatments, and preventing complications related to defoliant-associated disorders. Through these efforts, we aim to enhance the quality of veterans’ healthcare and bring hope to veterans and their families suffering from the aftereffects of defoliant exposure.